1. Home
  2. SOPH vs XOMA Comparison

SOPH vs XOMA Comparison

Compare SOPH & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOPH
  • XOMA
  • Stock Information
  • Founded
  • SOPH 2011
  • XOMA N/A
  • Country
  • SOPH Switzerland
  • XOMA United States
  • Employees
  • SOPH N/A
  • XOMA N/A
  • Industry
  • SOPH Biotechnology: Biological Products (No Diagnostic Substances)
  • XOMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOPH Health Care
  • XOMA Health Care
  • Exchange
  • SOPH Nasdaq
  • XOMA Nasdaq
  • Market Cap
  • SOPH 309.2M
  • XOMA 298.3M
  • IPO Year
  • SOPH 2021
  • XOMA N/A
  • Fundamental
  • Price
  • SOPH $4.71
  • XOMA $26.18
  • Analyst Decision
  • SOPH Strong Buy
  • XOMA Strong Buy
  • Analyst Count
  • SOPH 3
  • XOMA 2
  • Target Price
  • SOPH $7.33
  • XOMA $57.00
  • AVG Volume (30 Days)
  • SOPH 94.1K
  • XOMA 30.4K
  • Earning Date
  • SOPH 08-06-2024
  • XOMA 08-06-2024
  • Dividend Yield
  • SOPH N/A
  • XOMA N/A
  • EPS Growth
  • SOPH N/A
  • XOMA N/A
  • EPS
  • SOPH N/A
  • XOMA N/A
  • Revenue
  • SOPH $64,184,000.00
  • XOMA $5,811,000.00
  • Revenue This Year
  • SOPH $28.97
  • XOMA $349.94
  • Revenue Next Year
  • SOPH $28.39
  • XOMA $28.50
  • P/E Ratio
  • SOPH N/A
  • XOMA N/A
  • Revenue Growth
  • SOPH 26.68
  • XOMA 73.10
  • 52 Week Low
  • SOPH $2.13
  • XOMA $13.48
  • 52 Week High
  • SOPH $7.37
  • XOMA $27.36
  • Technical
  • Relative Strength Index (RSI)
  • SOPH 50.27
  • XOMA 55.75
  • Support Level
  • SOPH $4.50
  • XOMA $24.36
  • Resistance Level
  • SOPH $4.66
  • XOMA $27.10
  • Average True Range (ATR)
  • SOPH 0.21
  • XOMA 1.49
  • MACD
  • SOPH 0.01
  • XOMA 0.19
  • Stochastic Oscillator
  • SOPH 73.17
  • XOMA 82.44

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About XOMA XOMA Corporation

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

Share on Social Networks: